As Merck, AstraZeneca and other drugmakers sign on, Medicare price negotiations face critical moment
Merck Gets FDA Priority Review of Sotatercept in Pulmonary Arterial Hypertension >MRK
The Big Pharma Trade: Ozempic Is In, Covid-19 Is Out
Health Care Roundup: Market Talk
This Cancer Therapy is Lifesaving, but There Isn’t Enough of It
Eliquis for $55 a Month? That Is News to Us
Stocks Are Flat Ahead of Data
Apple, Moderna, Inflation, and More to Watch
Big Pharma’s Battle With the Biden Administration Could Have Legs
Biden FTC’s Antitrust Bark Proves Worse Than Its Bite
Medicare's Plan to Negotiate Drug Discounts Won't Hit Pharma Hard, Analysts say
Drug Price Controls Mean Slower Cures
Healthcare Shares Rise but Lag Broader Market -- Healthcare Roundup
First 10 Drugs Picked for Medicare Price Negotiations
Eliquis, Jardiance among first 10 drugs selected for Medicare price negotiations
The High Cost of Price Controls on Eliquis and Other Drugs
Biden Administration to Reveal 10 Drugs for Which Medicare Will Pay Less
BMY Gets European Approval for Opdivo as Treatment for Some Melanoma Patients
In a Tough Year for Pharma, These 6 Stocks Are Shining
Could Scientist Find Drug to Treat His Own Disease?
Recent
price
P/E
ratio
div
yld
3.89%
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.